Next Article in Journal
Single Exon Skipping Can Address a Multi-Exon Duplication in the Dystrophin Gene
Next Article in Special Issue
Binding of CML-Modified as Well as Heat-Glycated β-lactoglobulin to Receptors for AGEs Is Determined by Charge and Hydrophobicity
Previous Article in Journal
Sharing Marks: H3K4 Methylation and H2B Ubiquitination as Features of Meiotic Recombination and Transcription
Previous Article in Special Issue
Cannabis, the Endocannabinoid System and Immunity—the Journey from the Bedside to the Bench and Back

Pulmonary Involvement in a Mouse Model of Sjögren’s Syndrome Induced by STING Activation

Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2020, 21(12), 4512;
Received: 27 May 2020 / Revised: 22 June 2020 / Accepted: 23 June 2020 / Published: 25 June 2020
(This article belongs to the Special Issue Immunoregulatory Receptor Signaling Networks)
Sjögren’s Syndrome (SS), a chronic autoimmune disorder affecting multiple organ systems, is characterized by an elevated type I interferon (IFN) response. Activation of Stimulator of Interferon Genes (STING) protein induces type I IFN and in mice, several features of SS, including anti-nuclear antibodies, sialadenitis, and salivary gland dysfunction. Since lung involvement occurs in one-fifth of SS patients, we investigated whether systemic activation of STING also leads to lung inflammation. Lungs from female C57BL/6 mice injected with the STING agonist 5, 6-Dimethylxanthenone-4-acetic acid (DMXAA), were evaluated for acute and chronic inflammatory responses. Within 4h of DMXAA injection, the expression of Ifnb1, Il6, Tnf, Ifng, and Mx1 was significantly upregulated. At 1 and 2 months post-treatment, lungs showed lymphocytic infiltration in the peri-bronchial regions. The lungs from DMXAA treated mice showed an increased expression of multiple chemokines and an increase in lymphatic endothelial cells. Despite STING expression in bronchial epithelium and cells lining the alveolar wall, bone marrow chimeras between STING knockout and wild type mice showed that STING expression in hematopoietic cells was critical for lung inflammation. Our results suggest that activation of the STING pathway might be involved in SS patients with concomitant salivary gland and lung disease. View Full-Text
Keywords: Sjögren’s syndrome; STING; lung; interferon; salivary gland Sjögren’s syndrome; STING; lung; interferon; salivary gland
Show Figures

Figure 1

MDPI and ACS Style

Papinska, J.; Bagavant, H.; Gmyrek, G.B.; Deshmukh, U.S. Pulmonary Involvement in a Mouse Model of Sjögren’s Syndrome Induced by STING Activation. Int. J. Mol. Sci. 2020, 21, 4512.

AMA Style

Papinska J, Bagavant H, Gmyrek GB, Deshmukh US. Pulmonary Involvement in a Mouse Model of Sjögren’s Syndrome Induced by STING Activation. International Journal of Molecular Sciences. 2020; 21(12):4512.

Chicago/Turabian Style

Papinska, Joanna, Harini Bagavant, Grzegorz B. Gmyrek, and Umesh S. Deshmukh. 2020. "Pulmonary Involvement in a Mouse Model of Sjögren’s Syndrome Induced by STING Activation" International Journal of Molecular Sciences 21, no. 12: 4512.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop